Conclusions: Circulating mesothelin is a useful biomarker for pancreatic disease.
结论：对于胰腺疾病，循环中间皮素是一种有效的生物标记物。
This suggests that mesothelin is a potential target for immune-based intervention strategies in pancreatic cancer.
研究显示间皮素可作为胰腺癌患者以免疫治疗为基础的潜在的靶向治疗策略。
This suggests that mesothelin is a potential target for immune-based intervention strategies in pancreatic cancer.
研究显示间皮素可作为胰腺癌患者以免疫治疗为基础的潜在的靶向治疗策略。
应用推荐